Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Modulation of Soluble Interleukin 2 Receptor (sIL-2R) Levels in Patients with HIVWaldenstrom Macroglobulinemia (HIV-WM) Treated with Biaxin-Pentoxifylline-Dexamethasone Followed by Prednisolone (BPD-Pred)

Eugene McPherson, MD, PhD, P. Tassy, MD

Blood (2008) 112 (11): 5214.

https://doi.org/10.1182/blood.V112.11.5214.5214

Published: 2008

Journal Articles

Effects of Protease Inhibiton and Proteasome, Soluble Interleukin-2-Receptor (sIL-2R) in Biclonal Gammopathy-Human Immunodeficiency Virus Patients (BG-HIV).

Eugene McPherson, MD, PhD, E. Hazel, MD, P. Tassy, MD

Blood (2006) 108 (11): 3870.

https://doi.org/10.1182/blood.V108.11.3870.3870

Published: 2006

Journal Articles

Beta-2 Microglobulin and Soluble Interleukin-2 Receptor Serum Levels Correlates with Human Immunodeficiency Virus Associated Non-Hodgkins Lymphoma-Diffuse Large B-Cell Lymphoma (HIV-NHL-DLBCL).

Eugene McPherson, MD, PhD, J. Ng, RPh, MPh, E. Hazel, MD, P. Tassy, MD

Blood (2005) 106 (11): 4675.

https://doi.org/10.1182/blood.V106.11.4675.4675

Published: 2005

Journal Articles

Deficiency of 2,3-Dimethoxy-5-Methyl-6-Decaprenyl-1,4-Benzoquinone (Mitoquinone) and Hyperlactic Acidosis in Human Immunodeficiency Virus (HIV) Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) Treated with Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Based HAART and Chemoradiation.

Eugene McPherson, MD, PhD, E. Mejia, MD, E. Hazel, MD, P. Tassy, MD

Blood (2005) 106 (11): 3899.

https://doi.org/10.1182/blood.V106.11.3899.3899

Published: 2005

Journal Articles

Response of Elevated Serum Soluble Interleukin-2 Receptor (sIL-2R) and Overexpression of Glucose-6-Phosphate Dehydrogenase (G6PD) in Patients with Chronic Myelogenous Leukemia Treated with Imatinib Mesylate.

Eugene McPherson, MD, PhD, M. Shanmughan, MD, S.Y. Huang, MD, J. Kleinfeld, MD, E. Hazel, MD, P. Tassy, MD

Blood (2004) 104 (11): 4695.

https://doi.org/10.1182/blood.V104.11.4695.4695

Published: 2004

NARROW

Modulation of Soluble Interleukin 2 Receptor (sIL-2R) Levels in Patients with HIVWaldenstrom Macroglobulinemia (HIV-WM) Treated with Biaxin-Pentoxifylline-Dexamethasone Followed by Prednisolone (BPD-Pred)

Effects of Protease Inhibiton and Proteasome, Soluble Interleukin-2-Receptor (sIL-2R) in Biclonal Gammopathy-Human Immunodeficiency Virus Patients (BG-HIV).

Beta-2 Microglobulin and Soluble Interleukin-2 Receptor Serum Levels Correlates with Human Immunodeficiency Virus Associated Non-Hodgkins Lymphoma-Diffuse Large B-Cell Lymphoma (HIV-NHL-DLBCL).

Deficiency of 2,3-Dimethoxy-5-Methyl-6-Decaprenyl-1,4-Benzoquinone (Mitoquinone) and Hyperlactic Acidosis in Human Immunodeficiency Virus (HIV) Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) Treated with Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Based HAART and Chemoradiation.

Response of Elevated Serum Soluble Interleukin-2 Receptor (sIL-2R) and Overexpression of Glucose-6-Phosphate Dehydrogenase (G6PD) in Patients with Chronic Myelogenous Leukemia Treated with Imatinib Mesylate.

Email alerts

ASH Publications

American Society of Hematology

Modulation of Soluble Interleukin 2 Receptor (sIL-2R) Levels in Patients with HIVWaldenstrom Macroglobulinemia (HIV-WM) Treated with Biaxin-Pentoxifylline-Dexamethasone Followed by Prednisolone (BPD-Pred)

Effects of Protease Inhibiton and Proteasome, Soluble Interleukin-2-Receptor (sIL-2R) in Biclonal Gammopathy-Human Immunodeficiency Virus Patients (BG-HIV).

Beta-2 Microglobulin and Soluble Interleukin-2 Receptor Serum Levels Correlates with Human Immunodeficiency Virus Associated Non-Hodgkins Lymphoma-Diffuse Large B-Cell Lymphoma (HIV-NHL-DLBCL).

Deficiency of 2,3-Dimethoxy-5-Methyl-6-Decaprenyl-1,4-Benzoquinone (Mitoquinone) and Hyperlactic Acidosis in Human Immunodeficiency Virus (HIV) Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) Treated with Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Based HAART and Chemoradiation.

Response of Elevated Serum Soluble Interleukin-2 Receptor (sIL-2R) and Overexpression of Glucose-6-Phosphate Dehydrogenase (G6PD) in Patients with Chronic Myelogenous Leukemia Treated with Imatinib Mesylate.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only